Dave Kennedy, Managing Director at Aspire Ventures, Lancaster, Pennsylvania, United States — verified investor profile. See sector focus and contact routes.
Aspire Ventures has partnered with Penn Medicine Lancaster General Health (LG Health) to launch the Aspire Ventures Precision Medicine Fund (AVP). This fund aims to fast-track precision medicine technologies and practices that leverage AI and IoT to deliver affordable, individualized solutions at a massive scale. Aspire Ventures accelerates early-stage ventures with a support system of shared services, established processes, and proprietary technology components, such as their adaptive AI platform, A2I. They focus on an end-to-end ecosystem for accelerated healthcare innovation, from ideation to market adoption and insurance reimbursement.
This profile is part of the StartupFundraising investor database: focus, portfolio history, disclosed location and contact routes, refreshed as new filings and rounds are ingested. Founders use it to check fit before reaching out and to find investors in Lancaster.
Investors like Dave Kennedy · Full investor directory · Investor access · Company funding database